Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008

Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis

(2014) Mario Fernández-Ruiz et al.   CLINICAL INFECTIOUS DISEASES

Editorial Commentary: Is the Debate About Treatment of Candida parapsilosis Complex Infections With Echinocandins Much Ado About Nothing?

(2014) A. C. Reboli   CLINICAL INFECTIOUS DISEASES

Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin

(2013) A. Fekkar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care

(2013) Cornelius J. Clancy et al.   CLINICAL INFECTIOUS DISEASES

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Candida parapsilosis Is a Significant Neonatal Pathogen

(2013) Mohan Pammi et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

(2012) D. R. Andes et al.   CLINICAL INFECTIOUS DISEASES

Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011

(2012) A. A. Cleveland et al.   CLINICAL INFECTIOUS DISEASES

Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections

(2012) S.-H. Kim et al.   CLINICAL MICROBIOLOGY AND INFECTION

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008

(2012) Michael Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Treatment of Candida famata bloodstream infections: case series and review of the literature

(2012) N. D. Beyda et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

(2012) Mariana Castanheira et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme

(2012) Michael A. Pfaller et al.   MYCOPATHOLOGIA

Development of Echinocandin Resistance in Clavispora lusitaniae during Caspofungin Treatment

(2011) Marie Desnos-Ollivier et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients

(2010) Olivier Lortholary et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology of Invasive Mycoses in North America

(2010) Michael A. Pfaller et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program

(2010) Michael A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review

(2010) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

(2010) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

National Surveillance of Fungemia in Denmark (2004 to 2009)

(2010) M. C. Arendrup et al.   JOURNAL OF CLINICAL MICROBIOLOGY

What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast

(2010) Vincenzo Savini et al.   MYCOSES

Acquisition of Flucytosine, Azole, and Caspofungin Resistance in Candida glabrata Bloodstream Isolates Serially Obtained from a Hematopoietic Stem Cell Transplant Recipient

(2009) F. Chapeland-Leclerc et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007)

(2009) Nikolaos V. Sipsas et al.   CANCER

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)

(2009) Olivier Leroy et al.   CRITICAL CARE MEDICINE

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods

(2009) D. J. Diekema et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature

(2009) S. R. Lockhart et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The changing epidemiology of invasive candidiasis

(2008) Ray Hachem et al.   CANCER

Identification and Susceptibility Profile of Candida fermentati from a Worldwide Collection of Candida guilliermondii Clinical Isolates

(2008) S. R. Lockhart et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Debaryomyces hansenii (Candida famata), a Rare Human Fungal Pathogen Often Misidentified as Pichia guilliermondii (Candida guilliermondii)

(2008) M. Desnos-Ollivier et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Geographic and Temporal Trends in Isolation and Antifungal Susceptibility of Candida parapsilosis: a Global Assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Candida lusitaniaefungemia in cancer patients: risk factors for amphotericin B failure and outcome

(2008) Bradley J. Atkinson et al.   MEDICAL MYCOLOGY

Increasing incidence of Candida parapsilosis candidemia with caspofungin usage

(2007) Graeme N. Forrest et al.   JOURNAL OF INFECTION